Publication Name	World Journal of Ophthalmology
Manuscript ID	121730
DOI	10.5318/wjo.121730
Country	Lebanon

Category	Ophthalmology
Manuscript Type	Retrospective Cohort Study
Article Title	Efficacy of nightly 0.01% atropine in controlling myopia progression in Lebanese children: A 24-month retrospective cohort study
Manuscript Source	Unsolicited Manuscript
All Author List	Adel J Abi Rached, Carina K El Halabi, Yehya Tlaiss, Michael J Dounia and Anthony Saadeh
Funding Agency and Grant Number
Corresponding Author	Yehya Tlaiss, Department of Ophthalmology, Clémenceau Medical Center, Hazmieh, Beirut 1100, Beyrouth, Lebanon. yehyatlaiss@gmail.com
Key Words	Myopia; Atropine; Pediatric myopia; Myopia control; Low-dose atropine; Myopia progression
Core Tip	This is the first study to evaluate nightly 0.01% atropine for myopia control in Lebanese children. Over 24 months atropine-treated eyes demonstrated statistically significantly slower myopic progression than spectacle-only controls at multiple timepoints. No adverse effects were recorded. These findings extend existing evidence to the underrepresented Middle Eastern region. They support low-dose atropine as a safe, accessible and effective option for pediatric myopia management in Lebanon.
Citation	Abi Rached AJ, El Halabi CK, Tlaiss Y, Dounia MJ, Saadeh A. Efficacy of nightly 0.01% atropine in controlling myopia progression in Lebanese children: A 24-month retrospective cohort study. World J Ophthalmol 2026; In press DOI: https://doi.org/10.5318/wjo.121730
PDF	121730-in-press.pdf

Received	2026-03-31 01:08
Peer-Review Started	2026-03-31 01:43
First Decision by Editorial Office Director	2026-04-10 09:30
Return for Revision	2026-04-10 14:55
Revised	2026-04-27 17:54
Publication Fee Transferred
Second Decision by Editor	2026-06-23 02:19
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-06-23 08:36
Articles in Press	2026-06-23 08:36
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2218-6239 (online)
Open Access	This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com